The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization

作者: Jeong Won Jang , Jong Young Choi , Si Hyun Bae , Seung Kew Yoon , Hyun Young Woo

DOI: 10.1002/CNCR.22984

关键词:

摘要: BACKGROUND. Hepatocellular carcinoma (HCC) has a high tendency for recurrence after radical treatment. Apart from tumor and liver function parameters, little is known about the role of hepatitis B virus (HBV) factors in HCC. The objective this study was to identify potential relation between viral load HCC patients undergoing transarterial chemolipiodolization. METHODS. This cohort 62 consecutive who had HBV-related achieved complete necrosis with chemolipiodolization. Risk factors, including posttreatment recurrence, were analyzed. RESULTS. Overall, 32 (51.6%) developed during period (7.2–37.5 months). Multivariate analysis established Child-Pugh Class (P = .014), multiple tumors .013), (HBV DNA levels >105 copies/mL) at .001) as independent risk recurrence. On both univariate multivariate analyses, time identified strongest factor recurrence; moreover, its statistically significant effects still observed even when conducting analyses separately local .018) distant .009). CONCLUSIONS. Among individuals underwent chemolipiodolization, HBV among most important irrespective locational pattern current findings underscored need future work that tests applicability antiviral therapy reduce setting. Cancer 2007. © 2007 American Society.

参考文章(23)
Kenichi Takayasu, Yoshihisa Muramatsu, Tetsuo Maeda, Ryoko Iwata, Hiroyoshi Furukawa, Yukio Muramatsu, Noriyuki Moriyama, Takuji Okusaka, Shuichi Okada, Hideki Ueno, Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. American Journal of Roentgenology. ,vol. 176, pp. 681- 688 ,(2001) , 10.2214/AJR.176.3.1760681
Hiroaki Nagamatsu, Satoshi Itano, Sakae Nagaoka, Junji Akiyoshi, Satoru Matsugaki, Junichi Kurogi, Nobuyoshi Tajiri, Sanki Yamasaki, Hironori Koga, Takuji Torimura, Ryukichi Kumashiro, Michio Sata, Prophylactic Lamivudine Administration Prevents Exacerbation of Liver Damage in HBe Antigen Positive Patients with Hepatocellular Carcinoma Undergoing Transhepatic Arterial Infusion Chemotherapy The American Journal of Gastroenterology. ,vol. 99, pp. 2369- 2375 ,(2004) , 10.1111/J.1572-0241.2004.40069.X
Jeong Won Jang, Jong Young Choi, Si Hyun Bae, Seung Kew Yoon, U Im Chang, Chang Wook Kim, Se Hyun Cho, Jun Yeol Han, Young Sok Lee, A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization† Hepatology. ,vol. 43, pp. 233- 240 ,(2006) , 10.1002/HEP.21024
Shoji Kubo, Kazuhiro Hirohashi, Hiromu Tanaka, Tadashi Tsukamoto, Taichi Shuto, Takatsugu Yamamoto, Takashi Ikebe, Kenichi Wakasa, Shuhei Nishiguchi, Hiroaki Kinoshita, Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma. Cancer. ,vol. 88, pp. 1016- 1024 ,(2000) , 10.1002/(SICI)1097-0142(20000301)88:5<1016::AID-CNCR10>3.0.CO;2-V
MYOUNG KUK JANG, HAN CHU LEE, IN SOOK KIM, YOUNG-SUK LIM, YOUNG-HWA CHUNG, YUNG SANG LEE, KYU-BO SUNG, HYUN-KI YOON, GI-YOUNG KO, AH YOUNG KIM, DONG JIN SUH, Role of additional angiography and chemoembolization in patients with hepatocellular carcinoma who achieved complete necrosis following transarterial chemoembolization Journal of Gastroenterology and Hepatology. ,vol. 19, pp. 1074- 1080 ,(2004) , 10.1111/J.1440-1746.2004.03414.X
Anna SF Lok, None, Prevention of hepatitis B virus–related hepatocellular carcinoma Gastroenterology. ,vol. 127, pp. 303- 309 ,(2004) , 10.1053/J.GASTRO.2004.09.045
Mario Lise, Stefano Bacchetti, Pierpaolo Da Pian, Donato Nitti, Pier Luigi Pilati, Paolo Pigato, Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer. ,vol. 82, pp. 1028- 1036 ,(1998) , 10.1002/(SICI)1097-0142(19980315)82:6<1028::AID-CNCR4>3.0.CO;2-A
JAE KYUN LEE, YOUNG-HWA CHUNG, BYUNG-CHEOL SONG, JUNG WOO SHIN, WON-BEOM CHOI, SOO HYUN YANG, HYUN-KI YOON, KYU-BO SUNG, YUNG SANG LEE, DONG JIN SUH, Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization1 Journal of Gastroenterology and Hepatology. ,vol. 17, pp. 52- 58 ,(2002) , 10.1046/J.1440-1746.2002.02664.X
X.-R. Xu, J. Huang, Z.-G. Xu, B.-Z. Qian, Z.-D. Zhu, Q. Yan, T. Cai, X. Zhang, H.-S. Xiao, J. Qu, F. Liu, Q.-H. Huang, Z.-H. Cheng, N.-G. Li, J.-J. Du, W. Hu, K.-T. Shen, G. Lu, G. Fu, M. Zhong, S.-H. Xu, W.-Y. Gu, W. Huang, X.-T. Zhao, G.-X. Hu, J.-R. Gu, Z. Chen, Z.-G. Han, Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 98, pp. 15089- 15094 ,(2001) , 10.1073/PNAS.241522398
Jordi Bruix, Margarita Sala, Josep M. Llovet, Chemoembolization for hepatocellular carcinoma. Gastroenterology. ,vol. 127, pp. 179- 188 ,(2004) , 10.1053/J.GASTRO.2004.09.032